A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy Participants

NCT06719128 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Insufficiency
Healthy

Interventions

DRUG: Olomorasib

Sponsor

Eli Lilly and Company